During the past decade, SBI of Healthcare Samara Regional Clinical Oncology Dispensary conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 20 clinical trials were completed, i.e. on average, 90.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SBI of Healthcare Samara Regional Clinical Oncology Dispensary" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Merck Sharp & Dohme LLC" with 5 trials sponsored, "Biocad" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Helsinn Healthcare SA" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SBI of Healthcare Samara Regional Clinical Oncology Dispensary" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator and "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "SBI of Healthcare Samara Regional Clinical Oncology Dispensary" are "Breast Cancer" (8 trials), "Lung Cancer" (3 trials), "Metastatic Breast Cancer" (3 trials), "Non-small Cell Lung Cancer" (3 trials) and "Prostatic Neoplasms" (3 trials). Many other conditions were trialed in "SBI of Healthcare Samara Regional Clinical Oncology Dispensary" in a lesser frequency.

Most popular intervention types in "SBI of Healthcare Samara Regional Clinical Oncology Dispensary" are "Drug" (34 trials), "Biological" (9 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Paclitaxel" (8 trials), "Pembrolizumab" (8 trials), "Docetaxel" (7 trials) and "Trastuzumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "SBI of Healthcare Samara Regional Clinical Oncology Dispensary" are 27 trials for "All" genders, 6 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "SBI of Healthcare Samara Regional Clinical Oncology Dispensary". undefined are not yet recruiting, 4 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in SBI of Healthcare Samara Regional Clinical Oncology Dispensary, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in SBI of Healthcare Samara Regional Clinical Oncology Dispensary, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".